Filing Details
- Accession Number:
- 0001610717-23-000299
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-22 19:16:52
- Reporting Period:
- 2023-09-20
- Accepted Time:
- 2023-09-22 19:16:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501989 | Cytomx Therapeutics Inc. | CTMX | Pharmaceutical Preparations (2834) | 273521219 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1970752 | Marcia Belvin | C/O Cytomx Therapeutics, Inc. 151 Oyster Point Blvd., Ste. 400 South San Francisco CA 94080 | Svp, Chief Scientific Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-09-20 | 11,250 | $0.00 | 152,070 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2023-09-22 | 4,119 | $1.30 | 147,951 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents Performance Stock Units ("PSUs") initially granted on October 24, 2021 that were subject to a performance-based vesting condition. The second milestone vesting condition was determined to be satisfied upon which the remaining 50% of the PSUs vested.
- Includes 116,875 restricted stock units.
- The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of PSUs.
Billionaire Hedge Funds
